CClinicalTrials.gg
CompletedNCT06466213COPDUpdated Dec 4, 2025

Acute Effects of Three Different Types Single Leg Exercise in Copd

An interventional study of single exercise bout about one-leg exercise in Exercise, sponsored by Hacettepe University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2025-12-04.

Sponsored by Hacettepe University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Not applicable
Ages
40 Years and older
Sex
All
01

Study summary

COPD presents not only respiratory symtoms but also vascular or muscle dysfunction. Exercise training is important for aerobic performance increasing. Generally results show exercise training with both lower limb. Increaed arterial stiffness and muscle oxygenation are observed in COPD. One leg exercise result is not enough to highlight these parameters.

Read the detailed description

Acute Effects of Three Different Types Single Leg Exercise in Copd

single bout high intensity interval training

single bout continuous exercise training single bout resistance training

02

Conditions studied

  • Exercise

Browse trials for

03

In context

Motor Activity

2,426 studies on the registry are indexed under Motor Activity; 1,161 are open to participants now.

This study's enrollment of 26 is below the median of 60 across 2,118 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Hacettepe University is the lead sponsor of 983 studies on the registry; 212 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • COPD patients that applied to physiotherapy
  • cooperate to test
  • no severe ortopedical and neurological disease no severe cardiovascular disease volunteer to study

Exclusion criteria

Exclusion Criteria:

  • have an acute exacerbation
  • hypoxemia [PaO2] \<55 mmHg
  • no cooperated to test no volunteer to study having ortophedical and neurological diesase that affecting of tests having severe cardiovascular disease
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
26 participants (actual)

Study arms

  • Experimental
    single session one leg exercise intervantion in COPD

    first session: single session leg Continuous exercise intervantion will be applied to COPD. Unilaterally single leg continuous exercise will be performed as only one session second session : single session leg high intensity interval exercise intervantion will be applied to COPD. Unilaterally single leg hııt exercise will be performed as only one session third sessionsingle session leg resistance exercise intervantion will be applied to COPD. Respirocally leg strength (knee extantion ) exercise will be performed

    Other: single exercise bout about one-leg exercise

Interventions

  • Othersingle exercise bout about one-leg exercise

    cycle exercise includes single leg

06

What researchers measure

Primary outcomes

  1. six minute walk test

    six minute walk test in meter

    Time frame: beginning, day 1

Secondary outcomes

  1. cardiopulmonary exercise test

    VO2 max will be recorded as ml/kg/min will be recorded from incremental cycle cpet test

    Time frame: beginning, day 2

  2. single leg extremity test

    VO2 max will be recorded as ml/kg/min will be recorded from incremental cycle cpet test

    Time frame: beginning, day 3

  3. lung function

    FVC in % , FEV1 in %, FEV1/FVC ratio, PEF in % and FEF 25-75 in %

    Time frame: beginning, day 1

  4. muscle strength (isometric)

    quadriceps isometric muscle strength will be recorded as kilogram

    Time frame: beginning day 1

  5. muscle strength (10 repeated max)

    quadriceps 10 repeated max muscle strength will be recorded as kilogram

    Time frame: beginning, day 1

  6. continous exercise acute (single leg)

    VO2 max will be recorded as ml/kg/min will be performed from incremental cycle exercise at single session

    Time frame: beginning day 4

  7. high intensity interval training acute exercise (single leg)

    VO2 max will be recorded as ml/kg/min will be performed from incremental cycle exercise at single session

    Time frame: beginning day 5

  8. strength training acute exercise (single leg)

    VO2 max will be recorded as ml/kg/min will be performed from incremental cycle exercise at single session

    Time frame: beginning day 4,5,6

  9. muscle oxygenation

    minumum muscle oxygenation level will be presented as percentage

    Time frame: beginning day 4,5,6

  10. arterial stifness

    Aıx@75 in %

    Time frame: beginning day 2,3, 4,5,6

07

Study locations

1 site
  • Elif Kocaaga
    Ankara, Ankara, Turkey (Türkiye)
08

References and documents

Publications

  • Evans RA, Dolmage TE, Mangovski-Alzamora S, Romano J, O'Brien L, Brooks D, Goldstein RS. One-Legged Cycle Training for Chronic Obstructive Pulmonary Disease. A Pragmatic Study of Implementation to Pulmonary Rehabilitation. Ann Am Thorac Soc. 2015 Oct;12(10):1490-7. doi: 10.1513/AnnalsATS.201504-231OC. PubMed 26291542 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06466213
Lead sponsor
Hacettepe University
Responsible party
Elif Kocaaga (principal investigator, Hacettepe University) — Principal investigator
First posted
Jun 20, 2024
Start date
Feb 20, 2024
Primary completion
Mar 28, 2025
Completion
Mar 28, 2025
Last update
Dec 4, 2025

Study contacts

elif kocaaga, ms
principal investigator · Hacettepe University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion